54 filings from 2 registrants · 2008–2020 · latest filed Jan 18, 2021
Reported on its behalf
$2.5M
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$2.5M
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: edwards-lifesciences.
$570K
fees reported
›
Reading this · LD-2 reports a hired firm's fee and a registrant's reported expenses on separate lines and never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. Firm names link to their own record as the firms chapter lands.
32 filings
$1.5M on those filings
Medical/Disease Research/Clinical Labs
MED
4 filings
$160K on those filings
Budget/Appropriations
BUD
4 filings
$160K on those filings
Torts
TOR
4 filings
$160K on those filings
Copyright/Patent/Trademark
CPT
1 filing
$40K on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore spend on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
115th Congress
Protect Medical Innovation Act of 2018
8 filingsthrough 2018
H.R. 6114th Congress21st Century Cures Act7 filingsthrough 2016
H.R. 1265111th CongressNamed in the filings; no matching bill record on file.6 filingsthrough 2010
H.R. 759111th CongressNamed in the filings; no matching bill record on file.6 filingsthrough 2010
S. 506111th CongressNamed in the filings; no matching bill record on file.6 filingsthrough 2010
H.R. 160114th CongressProtect Medical Innovation Act of 20155 filingsthrough 2016
S. 149114th CongressMedical Device Access and Innovation Protection Act5 filingsthrough 2016
H.R. 1346111th CongressNamed in the filings; no matching bill record on file.5 filingsthrough 2010
S. 540111th CongressNamed in the filings; no matching bill record on file.5 filingsthrough 2010
S. 2221110th CongressTransparency in Medical Device Pricing Act of 20074 filingsthrough 2008
S. 631110th CongressRemote Monitoring Access Act of 20074 filingsthrough 2008
H.R. 1628115th CongressAmerican Health Care Act of 20173 filingsthrough 2017
How these are found · Bill references are extracted from the free-text activity description each filing writes, then matched to the Congress in session that filing year. A reference we can't match to a bill on file is still shown, unlinked — we cite what the filing said rather than guess at what it meant. Naming a bill is not a position on it: LD-2 records that a client lobbied on the bill, never which side.
through 2020
JOSEPH MICHAEL HOGAN jrAlpine Group Partners, LLC.Covered position: Deputy Chief of Staff, Sen. Ben Nelson13 filingsthrough 2019
Darren WebbOlsson, Frank, Weeda, Terman & Matz, PC7 filingsthrough 2020
BOB R BROOKS jrAlpine Group Partners, LLC.Covered position: Chief of Staff, Rep. Jim McCrery (R-LA)6 filingsthrough 2010
Elizabeth StowerOlsson, Frank, Weeda, Terman & Matz, PC2 filingsthrough 2020
Rebecca HawesAlpine Group Partners, LLC.Covered position: Legislative Counsel, Sen. John Breaux (D-LA)2 filingsthrough 2009
Covered positions · 6 of 9 lobbyists named on these filings disclosed a prior government post. The text is reproduced exactly as filed.
